Novel motif:44
From FANTOM5_SSTAR
name: | motif44_TGAAGST |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0045214 | sarcomere organization | 1.182871e-71 |
GO:0030240 | skeletal muscle thin filament assembly | 4.195586e-54 |
GO:0030239 | myofibril assembly | 6.191651e-51 |
GO:0030049 | muscle filament sliding | 4.096909e-50 |
GO:0070252 | actin-mediated cell contraction | 9.980659e-50 |
GO:0030048 | actin filament-based movement | 3.203203e-46 |
GO:0014866 | skeletal myofibril assembly | 1.520638e-44 |
GO:0031032 | actomyosin structure organization | 5.784375e-44 |
GO:0048739 | cardiac muscle fiber development | 1.202482e-42 |
GO:0006941 | striated muscle contraction | 9.029672e-38 |
GO:0048769 | sarcomerogenesis | 3.558475e-37 |
GO:0051592 | response to calcium ion | 1.315867e-35 |
GO:0032501 | multicellular organismal process | 2.251025e-35 |
GO:0055008 | cardiac muscle tissue morphogenesis | 3.015411e-35 |
GO:0010038 | response to metal ion | 5.014138e-35 |
GO:0010035 | response to inorganic substance | 1.983928e-33 |
GO:0055002 | striated muscle cell development | 9.619855e-33 |
GO:0007076 | mitotic chromosome condensation | 3.231179e-32 |
GO:0060415 | muscle tissue morphogenesis | 6.696556e-32 |
GO:0010927 | cellular component assembly involved in morphogenesis | 2.755351e-31 |
GO:0055003 | cardiac myofibril assembly | 7.018271e-31 |
GO:0048747 | muscle fiber development | 1.486776e-30 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 1.922092e-30 |
GO:0055001 | muscle cell development | 3.390425e-30 |
GO:0002576 | platelet degranulation | 4.710522e-30 |
GO:0048644 | muscle organ morphogenesis | 6.785490e-30 |
GO:0042692 | muscle cell differentiation | 2.545612e-29 |
GO:0051146 | striated muscle cell differentiation | 5.535588e-29 |
GO:0030168 | platelet activation | 2.602803e-27 |
GO:0007015 | actin filament organization | 7.600207e-27 |
GO:0001775 | cell activation | 3.780504e-26 |
GO:0050896 | response to stimulus | 1.817180e-25 |
GO:0000070 | mitotic sister chromatid segregation | 2.321943e-25 |
GO:0000819 | sister chromatid segregation | 3.742560e-25 |
GO:0065008 | regulation of biological quality | 1.196179e-24 |
GO:0055013 | cardiac muscle cell development | 4.363673e-24 |
GO:0048738 | cardiac muscle tissue development | 8.359943e-24 |
GO:0007522 | visceral muscle development | 1.770756e-23 |
GO:0006928 | cellular component movement | 4.389078e-23 |
GO:0006936 | muscle contraction | 2.538761e-22 |
GO:0018149 | peptide cross-linking | 2.808911e-22 |
GO:0055007 | cardiac muscle cell differentiation | 5.794231e-22 |
GO:0016192 | vesicle-mediated transport | 6.707044e-22 |
GO:0042060 | wound healing | 7.450745e-22 |
GO:0050878 | regulation of body fluid levels | 2.525361e-21 |
GO:0061061 | muscle structure development | 2.615040e-21 |
GO:0032502 | developmental process | 5.335608e-21 |
GO:0003012 | muscle system process | 5.688239e-21 |
GO:0030261 | chromosome condensation | 8.123361e-21 |
GO:0007596 | blood coagulation | 8.942012e-21 |
GO:0007599 | hemostasis | 3.911885e-20 |
GO:0071844 | cellular component assembly at cellular level | 1.107287e-19 |
GO:0006887 | exocytosis | 1.414132e-19 |
GO:0051234 | establishment of localization | 1.785812e-19 |
GO:0030029 | actin filament-based process | 2.630520e-19 |
GO:0032989 | cellular component morphogenesis | 2.873211e-19 |
GO:0032940 | secretion by cell | 3.522899e-19 |
GO:0048513 | organ development | 4.541267e-19 |
GO:0009611 | response to wounding | 7.750443e-19 |
GO:0035051 | cardiac cell differentiation | 8.125599e-19 |
GO:0048731 | system development | 1.723337e-18 |
GO:0048856 | anatomical structure development | 1.793984e-18 |
GO:0007517 | muscle organ development | 2.984483e-18 |
GO:0006810 | transport | 4.578064e-18 |
GO:0030036 | actin cytoskeleton organization | 5.083294e-18 |
GO:0006950 | response to stress | 6.115623e-18 |
GO:0046903 | secretion | 6.266737e-18 |
GO:0007275 | multicellular organismal development | 7.850563e-18 |
GO:0007010 | cytoskeleton organization | 8.093228e-18 |
GO:0014706 | striated muscle tissue development | 1.039163e-17 |
GO:0060537 | muscle tissue development | 2.413123e-17 |
GO:0022607 | cellular component assembly | 2.866342e-17 |
GO:0014829 | vascular smooth muscle contraction | 3.623482e-17 |
GO:0002376 | immune system process | 5.462830e-17 |
GO:0051249 | regulation of lymphocyte activation | 7.515014e-17 |
GO:0042221 | response to chemical stimulus | 7.803833e-17 |
GO:0010951 | negative regulation of endopeptidase activity | 4.855386e-16 |
GO:0050863 | regulation of T cell activation | 6.223402e-16 |
GO:0046687 | response to chromate | 6.859861e-16 |
GO:0033986 | response to methanol | 6.859861e-16 |
GO:0044085 | cellular component biogenesis | 7.066679e-16 |
GO:0034330 | cell junction organization | 2.356977e-15 |
GO:0034329 | cell junction assembly | 3.552302e-15 |
GO:0002694 | regulation of leukocyte activation | 7.845031e-15 |
GO:0048869 | cellular developmental process | 1.000117e-14 |
GO:0051179 | localization | 1.686252e-14 |
GO:0010466 | negative regulation of peptidase activity | 1.699477e-14 |
GO:0030154 | cell differentiation | 5.906702e-14 |
GO:0034014 | response to triglyceride | 7.259357e-14 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 7.519771e-14 |
GO:0044281 | small molecule metabolic process | 1.730004e-13 |
GO:0003008 | system process | 1.826111e-13 |
GO:0003007 | heart morphogenesis | 1.946909e-13 |
GO:0050870 | positive regulation of T cell activation | 2.264780e-13 |
GO:0002696 | positive regulation of leukocyte activation | 2.302870e-13 |
GO:0008217 | regulation of blood pressure | 2.650518e-13 |
GO:0051251 | positive regulation of lymphocyte activation | 2.788444e-13 |
GO:0021509 | roof plate formation | 4.723566e-13 |
GO:0031113 | regulation of microtubule polymerization | 5.312137e-13 |
GO:0043623 | cellular protein complex assembly | 5.486863e-13 |
GO:0051649 | establishment of localization in cell | 5.651054e-13 |
GO:0050865 | regulation of cell activation | 5.852145e-13 |
GO:0006953 | acute-phase response | 6.545414e-13 |
GO:0034332 | adherens junction organization | 7.141468e-13 |
GO:0051641 | cellular localization | 9.357784e-13 |
GO:0042310 | vasoconstriction | 1.045295e-12 |
GO:0016043 | cellular component organization | 1.254621e-12 |
GO:0072358 | cardiovascular system development | 1.416694e-12 |
GO:0051716 | cellular response to stimulus | 2.087102e-12 |
GO:0043462 | regulation of ATPase activity | 2.734427e-12 |
GO:0050867 | positive regulation of cell activation | 3.115146e-12 |
GO:0009888 | tissue development | 7.823102e-12 |
GO:0031424 | keratinization | 8.968906e-12 |
GO:0048685 | negative regulation of collateral sprouting of intact axon in response to injury | 2.207344e-11 |
GO:0043503 | skeletal muscle fiber adaptation | 2.223154e-11 |
GO:0007165 | signal transduction | 2.374911e-11 |
GO:0071840 | cellular component organization or biogenesis | 2.385773e-11 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 3.155546e-11 |
GO:0048468 | cell development | 4.080104e-11 |
GO:0009653 | anatomical structure morphogenesis | 4.239984e-11 |
GO:0050900 | leukocyte migration | 5.083942e-11 |
GO:0023052 | signaling | 5.093491e-11 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 5.188069e-11 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 5.439615e-11 |
GO:0009617 | response to bacterium | 6.108073e-11 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 6.332806e-11 |
GO:0051346 | negative regulation of hydrolase activity | 6.769523e-11 |
GO:0051707 | response to other organism | 1.170352e-10 |
GO:0009607 | response to biotic stimulus | 1.386549e-10 |
GO:0007507 | heart development | 1.840181e-10 |
GO:0007059 | chromosome segregation | 2.181660e-10 |
GO:0008207 | C21-steroid hormone metabolic process | 4.332224e-10 |
GO:0007154 | cell communication | 4.421327e-10 |
GO:0071379 | cellular response to prostaglandin stimulus | 4.791066e-10 |
GO:0050892 | intestinal absorption | 7.619922e-10 |
GO:0007166 | cell surface receptor linked signaling pathway | 9.148791e-10 |
GO:0006642 | triglyceride mobilization | 1.179813e-9 |
GO:0045216 | cell-cell junction organization | 1.226859e-9 |
GO:0042159 | lipoprotein catabolic process | 1.536711e-9 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.043622e-9 |
GO:0008202 | steroid metabolic process | 2.148646e-9 |
GO:0018350 | protein esterification | 2.231805e-9 |
GO:0044258 | intestinal lipid catabolic process | 2.231805e-9 |
GO:0007155 | cell adhesion | 2.536298e-9 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 2.706711e-9 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 2.750219e-9 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 4.101531e-9 |
GO:0002027 | regulation of heart rate | 4.828808e-9 |
GO:0071842 | cellular component organization at cellular level | 5.182505e-9 |
GO:0032886 | regulation of microtubule-based process | 6.277485e-9 |
GO:0044282 | small molecule catabolic process | 6.824389e-9 |
GO:0009117 | nucleotide metabolic process | 7.147202e-9 |
GO:0030509 | BMP signaling pathway | 7.241381e-9 |
GO:0042632 | cholesterol homeostasis | 7.323156e-9 |
GO:0009605 | response to external stimulus | 7.971385e-9 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 8.291873e-9 |
GO:0045621 | positive regulation of lymphocyte differentiation | 1.231377e-8 |
GO:0006898 | receptor-mediated endocytosis | 1.231455e-8 |
GO:0050670 | regulation of lymphocyte proliferation | 1.389485e-8 |
GO:0031295 | T cell costimulation | 1.411829e-8 |
GO:0006952 | defense response | 1.431482e-8 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 1.443064e-8 |
GO:0045582 | positive regulation of T cell differentiation | 1.467223e-8 |
GO:0002526 | acute inflammatory response | 1.523234e-8 |
GO:0009259 | ribonucleotide metabolic process | 1.533880e-8 |
GO:0050880 | regulation of blood vessel size | 1.638868e-8 |
GO:0060571 | morphogenesis of an epithelial fold | 1.659278e-8 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.807158e-8 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 1.846491e-8 |
GO:0006629 | lipid metabolic process | 1.979601e-8 |
GO:0007512 | adult heart development | 2.042885e-8 |
GO:0070663 | regulation of leukocyte proliferation | 2.069232e-8 |
GO:0006955 | immune response | 2.073457e-8 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 2.330905e-8 |
GO:0035150 | regulation of tube size | 2.411376e-8 |
GO:0008015 | blood circulation | 2.620166e-8 |
GO:0003013 | circulatory system process | 2.806398e-8 |
GO:0002026 | regulation of the force of heart contraction | 2.835688e-8 |
GO:0010288 | response to lead ion | 2.878851e-8 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.998263e-8 |
GO:0032944 | regulation of mononuclear cell proliferation | 3.158493e-8 |
GO:0052547 | regulation of peptidase activity | 3.320504e-8 |
GO:0048305 | immunoglobulin secretion | 3.481475e-8 |
GO:0007608 | sensory perception of smell | 3.552159e-8 |
GO:0009612 | response to mechanical stimulus | 3.633941e-8 |
GO:0030299 | intestinal cholesterol absorption | 3.876206e-8 |
GO:0000902 | cell morphogenesis | 4.701737e-8 |
GO:0046483 | heterocycle metabolic process | 5.111681e-8 |
GO:0045110 | intermediate filament bundle assembly | 5.219265e-8 |
GO:0007320 | insemination | 5.745600e-8 |
GO:0032924 | activin receptor signaling pathway | 5.893544e-8 |
GO:0006725 | cellular aromatic compound metabolic process | 6.405881e-8 |
GO:0019538 | protein metabolic process | 7.345191e-8 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 7.481622e-8 |
GO:0045580 | regulation of T cell differentiation | 7.823933e-8 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 9.392867e-8 |
GO:0007606 | sensory perception of chemical stimulus | 9.863658e-8 |
GO:0065007 | biological regulation | 9.948536e-8 |
GO:0006066 | alcohol metabolic process | 1.023954e-7 |
GO:0046314 | phosphocreatine biosynthetic process | 1.039207e-7 |
GO:0006323 | DNA packaging | 1.136171e-7 |
GO:0000904 | cell morphogenesis involved in differentiation | 1.268846e-7 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.335374e-7 |
GO:0001692 | histamine metabolic process | 1.492778e-7 |
GO:0010715 | regulation of extracellular matrix disassembly | 1.635728e-7 |
GO:0042953 | lipoprotein transport | 1.673279e-7 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.711709e-7 |
GO:0006457 | protein folding | 1.723233e-7 |
GO:0008211 | glucocorticoid metabolic process | 1.742792e-7 |
GO:0031116 | positive regulation of microtubule polymerization | 1.934074e-7 |
GO:0006600 | creatine metabolic process | 2.042531e-7 |
GO:0031115 | negative regulation of microtubule polymerization | 2.106375e-7 |
GO:0055088 | lipid homeostasis | 2.131887e-7 |
GO:0001694 | histamine biosynthetic process | 2.164366e-7 |
GO:0045575 | basophil activation | 2.164366e-7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 2.165817e-7 |
GO:0046709 | IDP catabolic process | 2.247873e-7 |
GO:0046032 | ADP catabolic process | 2.247873e-7 |
GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway | 2.653822e-7 |
GO:0009150 | purine ribonucleotide metabolic process | 2.789343e-7 |
GO:0050790 | regulation of catalytic activity | 3.030328e-7 |
GO:0071396 | cellular response to lipid | 3.055644e-7 |
GO:0002684 | positive regulation of immune system process | 3.241250e-7 |
GO:0034379 | very-low-density lipoprotein particle assembly | 3.312306e-7 |
GO:0006144 | purine base metabolic process | 3.327479e-7 |
GO:0006775 | fat-soluble vitamin metabolic process | 3.442802e-7 |
GO:0051336 | regulation of hydrolase activity | 3.854012e-7 |
GO:0009309 | amine biosynthetic process | 3.894918e-7 |
GO:0043086 | negative regulation of catalytic activity | 4.238840e-7 |
GO:0030888 | regulation of B cell proliferation | 4.418576e-7 |
GO:0009593 | detection of chemical stimulus | 4.688837e-7 |
GO:0001578 | microtubule bundle formation | 4.931556e-7 |
GO:0010040 | response to iron(II) ion | 5.337767e-7 |
GO:0007618 | mating | 5.404710e-7 |
GO:0048753 | pigment granule organization | 5.665025e-7 |
GO:0071243 | cellular response to arsenic-containing substance | 5.743127e-7 |
GO:0042396 | phosphagen biosynthetic process | 5.772405e-7 |
GO:0051250 | negative regulation of lymphocyte activation | 6.516364e-7 |
GO:0050776 | regulation of immune response | 7.896118e-7 |
GO:0019882 | antigen processing and presentation | 8.522136e-7 |
GO:0048545 | response to steroid hormone stimulus | 9.011679e-7 |
GO:0019433 | triglyceride catabolic process | 9.033148e-7 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 9.554065e-7 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 9.965368e-7 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 1.035820e-6 |
GO:0003127 | detection of nodal flow | 1.061282e-6 |
GO:0071103 | DNA conformation change | 1.068987e-6 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 1.092649e-6 |
GO:0006163 | purine nucleotide metabolic process | 1.159915e-6 |
GO:0030317 | sperm motility | 1.177970e-6 |
GO:0002697 | regulation of immune effector process | 1.200869e-6 |
GO:0032496 | response to lipopolysaccharide | 1.202861e-6 |
GO:0042363 | fat-soluble vitamin catabolic process | 1.239934e-6 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1.300120e-6 |
GO:0046503 | glycerolipid catabolic process | 1.332973e-6 |
GO:0046464 | acylglycerol catabolic process | 1.350858e-6 |
GO:0002090 | regulation of receptor internalization | 1.367012e-6 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1.407575e-6 |
GO:0002237 | response to molecule of bacterial origin | 1.431994e-6 |
GO:0051704 | multi-organism process | 1.441376e-6 |
GO:0006824 | cobalt ion transport | 1.451248e-6 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.532138e-6 |
GO:0008544 | epidermis development | 1.534300e-6 |
GO:0040011 | locomotion | 1.542158e-6 |
GO:0006508 | proteolysis | 1.576434e-6 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.725870e-6 |
GO:0009887 | organ morphogenesis | 1.732577e-6 |
GO:0006576 | cellular biogenic amine metabolic process | 1.800830e-6 |
GO:0009112 | nucleobase metabolic process | 1.906672e-6 |
GO:0045622 | regulation of T-helper cell differentiation | 1.930524e-6 |
GO:0061088 | regulation of sequestering of zinc ion | 1.980280e-6 |
GO:0010716 | negative regulation of extracellular matrix disassembly | 1.980280e-6 |
GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 2.105832e-6 |
GO:0042742 | defense response to bacterium | 2.119734e-6 |
GO:0016337 | cell-cell adhesion | 2.159360e-6 |
GO:0050869 | negative regulation of B cell activation | 2.191585e-6 |
GO:2000021 | regulation of ion homeostasis | 2.233560e-6 |
GO:0006547 | histidine metabolic process | 2.240943e-6 |
GO:0048878 | chemical homeostasis | 2.275927e-6 |
GO:0050671 | positive regulation of lymphocyte proliferation | 2.292401e-6 |
GO:0033693 | neurofilament bundle assembly | 2.536993e-6 |
GO:0006959 | humoral immune response | 2.667300e-6 |
GO:0051606 | detection of stimulus | 2.699876e-6 |
GO:0009310 | amine catabolic process | 2.726872e-6 |
GO:0050906 | detection of stimulus involved in sensory perception | 2.746258e-6 |
GO:0006811 | ion transport | 2.758959e-6 |
GO:0003209 | cardiac atrium morphogenesis | 2.767739e-6 |
GO:0009261 | ribonucleotide catabolic process | 2.770426e-6 |
GO:0044241 | lipid digestion | 2.806926e-6 |
GO:0010043 | response to zinc ion | 2.947911e-6 |
GO:0032438 | melanosome organization | 2.968992e-6 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 3.045029e-6 |
GO:0016050 | vesicle organization | 3.049062e-6 |
GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 3.068791e-6 |
GO:0071577 | zinc ion transmembrane transport | 3.072503e-6 |
GO:0042537 | benzene-containing compound metabolic process | 3.088253e-6 |
GO:0006548 | histidine catabolic process | 3.198658e-6 |
GO:0034754 | cellular hormone metabolic process | 3.258208e-6 |
GO:0030901 | midbrain development | 3.299497e-6 |
GO:0019896 | axon transport of mitochondrion | 3.322907e-6 |
GO:0014888 | striated muscle adaptation | 3.361546e-6 |
GO:0016049 | cell growth | 3.663196e-6 |
GO:0048683 | regulation of collateral sprouting of intact axon in response to injury | 3.728881e-6 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 3.756265e-6 |
GO:0042276 | error-prone translesion synthesis | 4.015428e-6 |
GO:0043501 | skeletal muscle adaptation | 4.042751e-6 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 4.215854e-6 |
GO:0048853 | forebrain morphogenesis | 4.382136e-6 |
GO:0044243 | multicellular organismal catabolic process | 4.382557e-6 |
GO:0072521 | purine-containing compound metabolic process | 4.492286e-6 |
GO:0006829 | zinc ion transport | 4.539079e-6 |
GO:0009154 | purine ribonucleotide catabolic process | 4.579871e-6 |
GO:0045923 | positive regulation of fatty acid metabolic process | 4.852910e-6 |
GO:0034383 | low-density lipoprotein particle clearance | 4.869851e-6 |
GO:0031175 | neuron projection development | 5.012625e-6 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 5.091126e-6 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt receptor signaling pathway | 5.174219e-6 |
GO:0044106 | cellular amine metabolic process | 5.358731e-6 |
GO:0030889 | negative regulation of B cell proliferation | 5.650923e-6 |
GO:0048729 | tissue morphogenesis | 5.668187e-6 |
GO:0048671 | negative regulation of collateral sprouting | 5.760910e-6 |
GO:0019932 | second-messenger-mediated signaling | 5.780212e-6 |
GO:0031581 | hemidesmosome assembly | 5.978960e-6 |
GO:0010886 | positive regulation of cholesterol storage | 5.988029e-6 |
GO:0042129 | regulation of T cell proliferation | 6.980114e-6 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 6.996146e-6 |
GO:0015918 | sterol transport | 7.030801e-6 |
GO:0003230 | cardiac atrium development | 7.107061e-6 |
GO:0003307 | regulation of Wnt receptor signaling pathway involved in heart development | 7.303093e-6 |
GO:0034377 | plasma lipoprotein particle assembly | 7.437878e-6 |
GO:0002637 | regulation of immunoglobulin production | 7.702822e-6 |
GO:0051023 | regulation of immunoglobulin secretion | 7.727196e-6 |
GO:0021527 | spinal cord association neuron differentiation | 7.727196e-6 |
GO:0050801 | ion homeostasis | 8.183372e-6 |
GO:0008652 | cellular amino acid biosynthetic process | 8.350138e-6 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 8.528151e-6 |
GO:0034723 | DNA replication-dependent nucleosome organization | 8.538927e-6 |
GO:0002682 | regulation of immune system process | 8.570978e-6 |
GO:0045619 | regulation of lymphocyte differentiation | 8.680881e-6 |
GO:0045624 | positive regulation of T-helper cell differentiation | 9.284078e-6 |
GO:0046700 | heterocycle catabolic process | 9.451142e-6 |
GO:0002695 | negative regulation of leukocyte activation | 9.667723e-6 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 9.714135e-6 |
GO:0043627 | response to estrogen stimulus | 9.796713e-6 |
GO:0018904 | organic ether metabolic process | 9.861837e-6 |
GO:0055069 | zinc ion homeostasis | 9.981460e-6 |
GO:0070271 | protein complex biogenesis | 1.012565e-5 |
GO:0048870 | cell motility | 1.016376e-5 |
GO:0030301 | cholesterol transport | 1.078696e-5 |
GO:0048245 | eosinophil chemotaxis | 1.146820e-5 |
GO:0031623 | receptor internalization | 1.157375e-5 |
GO:0009743 | response to carbohydrate stimulus | 1.160831e-5 |
GO:0008089 | anterograde axon cargo transport | 1.181412e-5 |
GO:0003018 | vascular process in circulatory system | 1.231849e-5 |
GO:0034776 | response to histamine | 1.236778e-5 |
GO:0006029 | proteoglycan metabolic process | 1.262995e-5 |
GO:0071466 | cellular response to xenobiotic stimulus | 1.283700e-5 |
GO:0055082 | cellular chemical homeostasis | 1.362355e-5 |
GO:0002699 | positive regulation of immune effector process | 1.386748e-5 |
GO:0044242 | cellular lipid catabolic process | 1.390411e-5 |
GO:0042592 | homeostatic process | 1.415112e-5 |
GO:0006461 | protein complex assembly | 1.435869e-5 |
GO:0014012 | peripheral nervous system axon regeneration | 1.454296e-5 |
GO:0070665 | positive regulation of leukocyte proliferation | 1.475080e-5 |
GO:0010970 | microtubule-based transport | 1.478033e-5 |
GO:0031579 | membrane raft organization | 1.500403e-5 |
GO:0034622 | cellular macromolecular complex assembly | 1.618849e-5 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 1.691635e-5 |
GO:0015889 | cobalamin transport | 1.719332e-5 |
GO:0007585 | respiratory gaseous exchange | 1.723150e-5 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.814873e-5 |
GO:0050868 | negative regulation of T cell activation | 1.935787e-5 |
GO:0009308 | amine metabolic process | 1.964522e-5 |
GO:0044092 | negative regulation of molecular function | 2.088029e-5 |
GO:0051258 | protein polymerization | 2.256076e-5 |
GO:0048676 | axon extension involved in development | 2.334160e-5 |
GO:0006897 | endocytosis | 2.335485e-5 |
GO:0034374 | low-density lipoprotein particle remodeling | 2.343387e-5 |
GO:0006584 | catecholamine metabolic process | 2.345802e-5 |
GO:0065009 | regulation of molecular function | 2.459174e-5 |
GO:0009987 | cellular process | 2.509017e-5 |
GO:0030216 | keratinocyte differentiation | 2.530646e-5 |
GO:0042157 | lipoprotein metabolic process | 2.623104e-5 |
GO:0006196 | AMP catabolic process | 2.655491e-5 |
GO:0046164 | alcohol catabolic process | 2.678695e-5 |
GO:0031214 | biomineral tissue development | 2.689485e-5 |
GO:0019725 | cellular homeostasis | 2.696606e-5 |
GO:0007044 | cell-substrate junction assembly | 2.710951e-5 |
GO:0050864 | regulation of B cell activation | 2.763156e-5 |
GO:0033059 | cellular pigmentation | 2.839132e-5 |
GO:0070741 | response to interleukin-6 | 2.853767e-5 |
GO:0042127 | regulation of cell proliferation | 2.860921e-5 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 2.863380e-5 |
GO:0009410 | response to xenobiotic stimulus | 2.918867e-5 |
GO:0060638 | mesenchymal-epithelial cell signaling | 2.931733e-5 |
GO:0046321 | positive regulation of fatty acid oxidation | 3.040248e-5 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 3.088243e-5 |
GO:0045104 | intermediate filament cytoskeleton organization | 3.125258e-5 |
GO:0009712 | catechol-containing compound metabolic process | 3.160852e-5 |
GO:0060539 | diaphragm development | 3.356162e-5 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 3.356162e-5 |
GO:0051953 | negative regulation of amine transport | 3.378822e-5 |
GO:0006873 | cellular ion homeostasis | 3.606904e-5 |
GO:0009165 | nucleotide biosynthetic process | 3.670857e-5 |
GO:0006447 | regulation of translational initiation by iron | 3.698783e-5 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 3.712809e-5 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 3.952365e-5 |
GO:0048790 | maintenance of presynaptic active zone structure | 3.952365e-5 |
GO:0016042 | lipid catabolic process | 3.963438e-5 |
GO:0006213 | pyrimidine nucleoside metabolic process | 3.986803e-5 |
GO:0019752 | carboxylic acid metabolic process | 4.030446e-5 |
GO:0042445 | hormone metabolic process | 4.187394e-5 |
GO:0006116 | NADH oxidation | 4.253406e-5 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 4.273314e-5 |
GO:0018958 | phenol-containing compound metabolic process | 4.467445e-5 |
GO:0006458 | 'de novo' protein folding | 4.617118e-5 |
GO:0006996 | organelle organization | 4.624786e-5 |
GO:0007409 | axonogenesis | 4.669085e-5 |
GO:0045109 | intermediate filament organization | 4.699119e-5 |
GO:0046649 | lymphocyte activation | 4.761854e-5 |
GO:0072523 | purine-containing compound catabolic process | 4.788290e-5 |
GO:0048660 | regulation of smooth muscle cell proliferation | 4.812336e-5 |
GO:0046634 | regulation of alpha-beta T cell activation | 4.971722e-5 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 5.005208e-5 |
GO:0044270 | cellular nitrogen compound catabolic process | 5.108818e-5 |
GO:0090381 | regulation of heart induction | 5.151498e-5 |
GO:0048858 | cell projection morphogenesis | 5.308798e-5 |
GO:0001964 | startle response | 5.476417e-5 |
GO:0046395 | carboxylic acid catabolic process | 5.670729e-5 |
GO:0009063 | cellular amino acid catabolic process | 5.760460e-5 |
GO:0042325 | regulation of phosphorylation | 5.855879e-5 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 5.950132e-5 |
GO:0015698 | inorganic anion transport | 5.962782e-5 |
GO:0050789 | regulation of biological process | 6.056027e-5 |
GO:0042832 | defense response to protozoan | 6.143729e-5 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.190443e-5 |
GO:0008285 | negative regulation of cell proliferation | 6.241237e-5 |
GO:0019220 | regulation of phosphate metabolic process | 6.286957e-5 |
GO:0010155 | regulation of proton transport | 6.289358e-5 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 6.317847e-5 |
GO:0001932 | regulation of protein phosphorylation | 6.318589e-5 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 6.331971e-5 |
GO:0048666 | neuron development | 6.430682e-5 |
GO:0032844 | regulation of homeostatic process | 6.435209e-5 |
GO:0031099 | regeneration | 6.453758e-5 |
GO:0006957 | complement activation, alternative pathway | 6.458626e-5 |
GO:0090181 | regulation of cholesterol metabolic process | 6.663952e-5 |
GO:0019217 | regulation of fatty acid metabolic process | 6.835961e-5 |
GO:0048854 | brain morphogenesis | 6.909818e-5 |
GO:0009100 | glycoprotein metabolic process | 7.046074e-5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 7.070762e-5 |
GO:0002819 | regulation of adaptive immune response | 7.075177e-5 |
GO:0006869 | lipid transport | 7.087093e-5 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 7.155703e-5 |
GO:0060070 | canonical Wnt receptor signaling pathway | 7.343429e-5 |
GO:0060134 | prepulse inhibition | 7.356681e-5 |
GO:0032990 | cell part morphogenesis | 7.375297e-5 |
GO:0030030 | cell projection organization | 7.698020e-5 |
GO:0052548 | regulation of endopeptidase activity | 7.705719e-5 |
GO:0044356 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine | 7.709911e-5 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 7.780275e-5 |
GO:0090066 | regulation of anatomical structure size | 7.810739e-5 |
GO:0042180 | cellular ketone metabolic process | 7.854604e-5 |
GO:0042102 | positive regulation of T cell proliferation | 7.860171e-5 |
GO:0009791 | post-embryonic development | 7.879451e-5 |
GO:0007156 | homophilic cell adhesion | 7.972983e-5 |
GO:0010977 | negative regulation of neuron projection development | 7.974271e-5 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 8.009553e-5 |
GO:0032355 | response to estradiol stimulus | 8.169189e-5 |
GO:0050866 | negative regulation of cell activation | 8.224320e-5 |
GO:0045321 | leukocyte activation | 8.365605e-5 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 8.665930e-5 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 8.783699e-5 |
GO:0009260 | ribonucleotide biosynthetic process | 8.934091e-5 |
GO:0034694 | response to prostaglandin stimulus | 8.961460e-5 |
GO:0048812 | neuron projection morphogenesis | 9.101115e-5 |
GO:0050778 | positive regulation of immune response | 9.223561e-5 |
GO:0007259 | JAK-STAT cascade | 9.321442e-5 |
GO:0034655 | nucleobase-containing compound catabolic process | 9.356439e-5 |
GO:0044283 | small molecule biosynthetic process | 9.507804e-5 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 9.509391e-5 |
GO:0050709 | negative regulation of protein secretion | 9.565995e-5 |
GO:0047497 | mitochondrion transport along microtubule | 9.687613e-5 |
GO:0006805 | xenobiotic metabolic process | 9.760101e-5 |
GO:0050852 | T cell receptor signaling pathway | 9.789202e-5 |
GO:0030953 | astral microtubule organization | 1.006090e-4 |
GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 1.018591e-4 |
GO:0031399 | regulation of protein modification process | 1.019527e-4 |
GO:0009056 | catabolic process | 1.045626e-4 |
GO:0003203 | endocardial cushion morphogenesis | 1.049224e-4 |
GO:0016477 | cell migration | 1.053425e-4 |
GO:0009913 | epidermal cell differentiation | 1.054391e-4 |
GO:0042483 | negative regulation of odontogenesis | 1.069067e-4 |
GO:0016246 | RNA interference | 1.069067e-4 |
GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 1.075057e-4 |
GO:0044248 | cellular catabolic process | 1.106279e-4 |
GO:0002683 | negative regulation of immune system process | 1.119972e-4 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 1.136007e-4 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.149828e-4 |
GO:0042758 | long-chain fatty acid catabolic process | 1.163959e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006952 | defense response | 2.872061e-21 |
GO:0050896 | response to stimulus | 3.411238e-21 |
GO:0042221 | response to chemical stimulus | 5.401943e-17 |
GO:0003012 | muscle system process | 4.129777e-15 |
GO:0010035 | response to inorganic substance | 4.196731e-15 |
GO:0008202 | steroid metabolic process | 4.096180e-14 |
GO:0055114 | oxidation-reduction process | 5.876185e-14 |
GO:0007512 | adult heart development | 7.017106e-14 |
GO:0050863 | regulation of T cell activation | 3.309280e-13 |
GO:0006936 | muscle contraction | 3.390505e-13 |
GO:0006950 | response to stress | 5.065262e-13 |
GO:0051249 | regulation of lymphocyte activation | 9.351243e-13 |
GO:0050870 | positive regulation of T cell activation | 1.771400e-12 |
GO:0051704 | multi-organism process | 2.103048e-12 |
GO:0006629 | lipid metabolic process | 4.611151e-12 |
GO:0050867 | positive regulation of cell activation | 9.730386e-12 |
GO:0002694 | regulation of leukocyte activation | 1.570509e-11 |
GO:0050865 | regulation of cell activation | 1.766020e-11 |
GO:0010033 | response to organic substance | 1.846643e-11 |
GO:0002696 | positive regulation of leukocyte activation | 3.753842e-11 |
GO:0009607 | response to biotic stimulus | 6.520185e-11 |
GO:0043056 | forward locomotion | 1.199314e-10 |
GO:0002684 | positive regulation of immune system process | 1.630675e-10 |
GO:0016125 | sterol metabolic process | 1.859426e-10 |
GO:0043434 | response to peptide hormone stimulus | 2.639800e-10 |
GO:0051707 | response to other organism | 2.658711e-10 |
GO:0046464 | acylglycerol catabolic process | 3.018532e-10 |
GO:0009725 | response to hormone stimulus | 4.397127e-10 |
GO:0034369 | plasma lipoprotein particle remodeling | 6.089500e-10 |
GO:0051251 | positive regulation of lymphocyte activation | 7.449254e-10 |
GO:0042742 | defense response to bacterium | 7.708096e-10 |
GO:0008203 | cholesterol metabolic process | 1.380030e-9 |
GO:0044255 | cellular lipid metabolic process | 1.409595e-9 |
GO:0033058 | directional locomotion | 2.870317e-9 |
GO:0006278 | RNA-dependent DNA replication | 3.251837e-9 |
GO:0046503 | glycerolipid catabolic process | 3.471468e-9 |
GO:0002376 | immune system process | 4.314723e-9 |
GO:0006955 | immune response | 4.854363e-9 |
GO:0050670 | regulation of lymphocyte proliferation | 5.147050e-9 |
GO:0010873 | positive regulation of cholesterol esterification | 6.059455e-9 |
GO:0031341 | regulation of cell killing | 6.502499e-9 |
GO:0006066 | alcohol metabolic process | 8.463896e-9 |
GO:0032101 | regulation of response to external stimulus | 8.636001e-9 |
GO:0070663 | regulation of leukocyte proliferation | 8.638410e-9 |
GO:0002682 | regulation of immune system process | 9.412806e-9 |
GO:0032944 | regulation of mononuclear cell proliferation | 9.464120e-9 |
GO:0010038 | response to metal ion | 1.131302e-8 |
GO:0009617 | response to bacterium | 1.309904e-8 |
GO:0016042 | lipid catabolic process | 1.485850e-8 |
GO:0042129 | regulation of T cell proliferation | 1.758007e-8 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 1.944963e-8 |
GO:0031347 | regulation of defense response | 2.933404e-8 |
GO:0051716 | cellular response to stimulus | 3.097122e-8 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 3.529359e-8 |
GO:0060052 | neurofilament cytoskeleton organization | 3.601014e-8 |
GO:0032501 | multicellular organismal process | 3.966204e-8 |
GO:0006953 | acute-phase response | 4.219883e-8 |
GO:0044242 | cellular lipid catabolic process | 4.252859e-8 |
GO:0006941 | striated muscle contraction | 4.460392e-8 |
GO:0009719 | response to endogenous stimulus | 6.648532e-8 |
GO:0010872 | regulation of cholesterol esterification | 7.522188e-8 |
GO:0033687 | osteoblast proliferation | 7.869269e-8 |
GO:0051346 | negative regulation of hydrolase activity | 8.246991e-8 |
GO:0002227 | innate immune response in mucosa | 8.432834e-8 |
GO:0071827 | plasma lipoprotein particle organization | 8.792418e-8 |
GO:0055090 | acylglycerol homeostasis | 8.925492e-8 |
GO:0002706 | regulation of lymphocyte mediated immunity | 9.496292e-8 |
GO:0019218 | regulation of steroid metabolic process | 1.059840e-7 |
GO:0033275 | actin-myosin filament sliding | 1.116609e-7 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 1.324793e-7 |
GO:0071396 | cellular response to lipid | 1.397267e-7 |
GO:0043648 | dicarboxylic acid metabolic process | 1.406927e-7 |
GO:0065008 | regulation of biological quality | 1.664837e-7 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 1.867730e-7 |
GO:0030240 | skeletal muscle thin filament assembly | 1.944342e-7 |
GO:0006082 | organic acid metabolic process | 1.962659e-7 |
GO:0019433 | triglyceride catabolic process | 2.012786e-7 |
GO:0045103 | intermediate filament-based process | 2.174078e-7 |
GO:0034374 | low-density lipoprotein particle remodeling | 2.493114e-7 |
GO:0050930 | induction of positive chemotaxis | 2.854668e-7 |
GO:0044281 | small molecule metabolic process | 2.859051e-7 |
GO:0031295 | T cell costimulation | 3.053732e-7 |
GO:0070252 | actin-mediated cell contraction | 3.063864e-7 |
GO:0060754 | positive regulation of mast cell chemotaxis | 3.136801e-7 |
GO:0019285 | glycine betaine biosynthetic process from choline | 3.319573e-7 |
GO:0045104 | intermediate filament cytoskeleton organization | 3.745304e-7 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 4.007213e-7 |
GO:0002027 | regulation of heart rate | 4.891257e-7 |
GO:0014866 | skeletal myofibril assembly | 5.627796e-7 |
GO:0018904 | organic ether metabolic process | 6.823722e-7 |
GO:0006982 | response to lipid hydroperoxide | 7.276128e-7 |
GO:0010466 | negative regulation of peptidase activity | 7.437748e-7 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 7.882193e-7 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 7.975880e-7 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 7.995956e-7 |
GO:0045940 | positive regulation of steroid metabolic process | 8.080121e-7 |
GO:0032870 | cellular response to hormone stimulus | 8.264942e-7 |
GO:0010927 | cellular component assembly involved in morphogenesis | 8.634652e-7 |
GO:0040018 | positive regulation of multicellular organism growth | 8.655538e-7 |
GO:0045621 | positive regulation of lymphocyte differentiation | 9.235397e-7 |
GO:0031342 | negative regulation of cell killing | 9.468510e-7 |
GO:0009743 | response to carbohydrate stimulus | 9.494175e-7 |
GO:0043279 | response to alkaloid | 9.560803e-7 |
GO:0000305 | response to oxygen radical | 1.004887e-6 |
GO:0050766 | positive regulation of phagocytosis | 1.099025e-6 |
GO:0019752 | carboxylic acid metabolic process | 1.153961e-6 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 1.163615e-6 |
GO:0001878 | response to yeast | 1.169757e-6 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 1.209936e-6 |
GO:0006820 | anion transport | 1.212686e-6 |
GO:0009611 | response to wounding | 1.213859e-6 |
GO:0042180 | cellular ketone metabolic process | 1.234172e-6 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.291212e-6 |
GO:0009605 | response to external stimulus | 1.306613e-6 |
GO:0002683 | negative regulation of immune system process | 1.326678e-6 |
GO:0060695 | negative regulation of cholesterol transporter activity | 1.367275e-6 |
GO:0015759 | beta-glucoside transport | 1.367275e-6 |
GO:0043462 | regulation of ATPase activity | 1.408324e-6 |
GO:0007522 | visceral muscle development | 1.409690e-6 |
GO:0030239 | myofibril assembly | 1.474927e-6 |
GO:0009056 | catabolic process | 1.724101e-6 |
GO:0042743 | hydrogen peroxide metabolic process | 1.821759e-6 |
GO:0003008 | system process | 1.854291e-6 |
GO:0042439 | ethanolamine-containing compound metabolic process | 1.952504e-6 |
GO:0031343 | positive regulation of cell killing | 2.077419e-6 |
GO:0045658 | regulation of neutrophil differentiation | 2.221742e-6 |
GO:0042946 | glucoside transport | 2.576669e-6 |
GO:0001920 | negative regulation of receptor recycling | 2.576669e-6 |
GO:0045087 | innate immune response | 2.592250e-6 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 2.650946e-6 |
GO:0000303 | response to superoxide | 2.672721e-6 |
GO:0071375 | cellular response to peptide hormone stimulus | 2.731220e-6 |
GO:0019430 | removal of superoxide radicals | 3.068170e-6 |
GO:0070887 | cellular response to chemical stimulus | 3.169049e-6 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 3.659589e-6 |
GO:0006694 | steroid biosynthetic process | 3.751238e-6 |
GO:0072593 | reactive oxygen species metabolic process | 4.239077e-6 |
GO:0042102 | positive regulation of T cell proliferation | 4.557628e-6 |
GO:0030301 | cholesterol transport | 4.731692e-6 |
GO:0050672 | negative regulation of lymphocyte proliferation | 4.945176e-6 |
GO:0000302 | response to reactive oxygen species | 4.959085e-6 |
GO:0034435 | cholesterol esterification | 5.097483e-6 |
GO:0002526 | acute inflammatory response | 5.113353e-6 |
GO:0032536 | regulation of cell projection size | 5.211881e-6 |
GO:0045582 | positive regulation of T cell differentiation | 5.344842e-6 |
GO:0002703 | regulation of leukocyte mediated immunity | 5.646733e-6 |
GO:0070664 | negative regulation of leukocyte proliferation | 5.712076e-6 |
GO:0006801 | superoxide metabolic process | 5.795923e-6 |
GO:0031032 | actomyosin structure organization | 5.887691e-6 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 6.224845e-6 |
GO:0051241 | negative regulation of multicellular organismal process | 6.525570e-6 |
GO:0080134 | regulation of response to stress | 6.709768e-6 |
GO:0019216 | regulation of lipid metabolic process | 6.860460e-6 |
GO:0032869 | cellular response to insulin stimulus | 6.948986e-6 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 7.205432e-6 |
GO:0051240 | positive regulation of multicellular organismal process | 7.549344e-6 |
GO:0031099 | regeneration | 7.692773e-6 |
GO:0050727 | regulation of inflammatory response | 7.781514e-6 |
GO:0008610 | lipid biosynthetic process | 8.090971e-6 |
GO:0035634 | response to stilbenoid | 8.506404e-6 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 8.556522e-6 |
GO:0002920 | regulation of humoral immune response | 8.648345e-6 |
GO:0007154 | cell communication | 9.311741e-6 |
GO:0014070 | response to organic cyclic compound | 9.535711e-6 |
GO:0045619 | regulation of lymphocyte differentiation | 9.977963e-6 |
GO:0046967 | cytosol to ER transport | 1.022974e-5 |
GO:0019060 | intracellular transport of viral proteins in host cell | 1.022974e-5 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 1.059347e-5 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.090066e-5 |
GO:0002922 | positive regulation of humoral immune response | 1.172331e-5 |
GO:0034442 | regulation of lipoprotein oxidation | 1.183311e-5 |
GO:0055003 | cardiac myofibril assembly | 1.203717e-5 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 1.208375e-5 |
GO:0006816 | calcium ion transport | 1.258846e-5 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 1.259574e-5 |
GO:0048545 | response to steroid hormone stimulus | 1.321872e-5 |
GO:0071495 | cellular response to endogenous stimulus | 1.324889e-5 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.326188e-5 |
GO:0002819 | regulation of adaptive immune response | 1.352723e-5 |
GO:0045214 | sarcomere organization | 1.352731e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.390060e-5 |
GO:0009566 | fertilization | 1.435589e-5 |
GO:0023052 | signaling | 1.490203e-5 |
GO:0043086 | negative regulation of catalytic activity | 1.506150e-5 |
GO:0006639 | acylglycerol metabolic process | 1.532688e-5 |
GO:0050764 | regulation of phagocytosis | 1.546359e-5 |
GO:0045671 | negative regulation of osteoclast differentiation | 1.666942e-5 |
GO:0032656 | regulation of interleukin-13 production | 1.715680e-5 |
GO:0002820 | negative regulation of adaptive immune response | 1.777344e-5 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.796931e-5 |
GO:0060716 | labyrinthine layer blood vessel development | 1.825189e-5 |
GO:0045580 | regulation of T cell differentiation | 1.849210e-5 |
GO:0072511 | divalent inorganic cation transport | 1.859444e-5 |
GO:0045109 | intermediate filament organization | 1.871820e-5 |
GO:0046340 | diacylglycerol catabolic process | 1.879617e-5 |
GO:0040008 | regulation of growth | 1.938129e-5 |
GO:0007600 | sensory perception | 1.969050e-5 |
GO:0006979 | response to oxidative stress | 1.981538e-5 |
GO:0045927 | positive regulation of growth | 2.106787e-5 |
GO:0032868 | response to insulin stimulus | 2.150060e-5 |
GO:0010269 | response to selenium ion | 2.165651e-5 |
GO:0006706 | steroid catabolic process | 2.181606e-5 |
GO:0033194 | response to hydroperoxide | 2.191702e-5 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 2.204065e-5 |
GO:0031133 | regulation of axon diameter | 2.254589e-5 |
GO:0032696 | negative regulation of interleukin-13 production | 2.346504e-5 |
GO:0010954 | positive regulation of protein processing | 2.387845e-5 |
GO:0006638 | neutral lipid metabolic process | 2.714384e-5 |
GO:0051250 | negative regulation of lymphocyte activation | 2.720543e-5 |
GO:0050671 | positive regulation of lymphocyte proliferation | 3.205143e-5 |
GO:0001887 | selenium compound metabolic process | 3.217100e-5 |
GO:0046890 | regulation of lipid biosynthetic process | 3.345315e-5 |
GO:0051138 | positive regulation of NK T cell differentiation | 3.437758e-5 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 3.437758e-5 |
GO:0018894 | dibenzo-p-dioxin metabolic process | 3.437758e-5 |
GO:0050776 | regulation of immune response | 3.500959e-5 |
GO:0006968 | cellular defense response | 3.635414e-5 |
GO:0031953 | negative regulation of protein autophosphorylation | 3.672542e-5 |
GO:0070838 | divalent metal ion transport | 3.751164e-5 |
GO:0030049 | muscle filament sliding | 3.894694e-5 |
GO:0002385 | mucosal immune response | 3.897248e-5 |
GO:0006014 | D-ribose metabolic process | 3.975490e-5 |
GO:0002251 | organ or tissue specific immune response | 3.975490e-5 |
GO:0060056 | mammary gland involution | 4.068184e-5 |
GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.542420e-5 |
GO:0070665 | positive regulation of leukocyte proliferation | 4.554524e-5 |
GO:0008299 | isoprenoid biosynthetic process | 4.704681e-5 |
GO:0042632 | cholesterol homeostasis | 4.788272e-5 |
GO:0051239 | regulation of multicellular organismal process | 4.793375e-5 |
GO:0006811 | ion transport | 4.883440e-5 |
GO:0044243 | multicellular organismal catabolic process | 4.904467e-5 |
GO:0017144 | drug metabolic process | 4.925497e-5 |
GO:0045751 | negative regulation of Toll signaling pathway | 4.936350e-5 |
GO:0032462 | regulation of protein homooligomerization | 5.016110e-5 |
GO:0030300 | regulation of intestinal cholesterol absorption | 5.034161e-5 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 5.154706e-5 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 5.311726e-5 |
GO:0014904 | myotube cell development | 5.329764e-5 |
GO:0034383 | low-density lipoprotein particle clearance | 5.707689e-5 |
GO:0060765 | regulation of androgen receptor signaling pathway | 5.971241e-5 |
GO:0050906 | detection of stimulus involved in sensory perception | 6.070046e-5 |
GO:0014012 | peripheral nervous system axon regeneration | 6.087356e-5 |
GO:0045409 | negative regulation of interleukin-6 biosynthetic process | 6.154513e-5 |
GO:0009991 | response to extracellular stimulus | 6.220401e-5 |
GO:0001969 | regulation of activation of membrane attack complex | 7.098644e-5 |
GO:0043603 | cellular amide metabolic process | 7.271965e-5 |
GO:0032094 | response to food | 7.273276e-5 |
GO:0015698 | inorganic anion transport | 7.281276e-5 |
GO:0048583 | regulation of response to stimulus | 7.499437e-5 |
GO:0034381 | plasma lipoprotein particle clearance | 7.692375e-5 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 7.773755e-5 |
GO:0045660 | positive regulation of neutrophil differentiation | 7.879549e-5 |
GO:0042098 | T cell proliferation | 7.901653e-5 |
GO:0030321 | transepithelial chloride transport | 8.185849e-5 |
GO:0060401 | cytosolic calcium ion transport | 8.270008e-5 |
GO:0030001 | metal ion transport | 8.670533e-5 |
GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway | 8.740227e-5 |
GO:0030048 | actin filament-based movement | 8.783400e-5 |
GO:0006662 | glycerol ether metabolic process | 8.819563e-5 |
GO:0034284 | response to monosaccharide stimulus | 9.396448e-5 |
GO:0032663 | regulation of interleukin-2 production | 9.613746e-5 |
GO:0044130 | negative regulation of growth of symbiont in host | 9.654821e-5 |
GO:0006578 | betaine biosynthetic process | 1.007985e-4 |
GO:0052547 | regulation of peptidase activity | 1.021049e-4 |
GO:0007608 | sensory perception of smell | 1.061622e-4 |
GO:0044248 | cellular catabolic process | 1.073950e-4 |
GO:0051146 | striated muscle cell differentiation | 1.106454e-4 |
GO:0032689 | negative regulation of interferon-gamma production | 1.166488e-4 |
GO:0051592 | response to calcium ion | 1.167208e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 1.178266e-4 |
GO:0050769 | positive regulation of neurogenesis | 1.218316e-4 |
GO:0045088 | regulation of innate immune response | 1.259893e-4 |
GO:0046006 | regulation of activated T cell proliferation | 1.265597e-4 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 1.313707e-4 |
GO:0044057 | regulation of system process | 1.323412e-4 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.336569e-4 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 1.337217e-4 |
GO:0007165 | signal transduction | 1.343572e-4 |
GO:0033993 | response to lipid | 1.395163e-4 |
GO:0032673 | regulation of interleukin-4 production | 1.395843e-4 |
GO:0042104 | positive regulation of activated T cell proliferation | 1.418154e-4 |
GO:0006732 | coenzyme metabolic process | 1.425991e-4 |
GO:0032459 | regulation of protein oligomerization | 1.435778e-4 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 1.465294e-4 |
GO:0048739 | cardiac muscle fiber development | 1.481916e-4 |
GO:0033344 | cholesterol efflux | 1.491842e-4 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.518886e-4 |
GO:0032713 | negative regulation of interleukin-4 production | 1.549288e-4 |
GO:0050777 | negative regulation of immune response | 1.566742e-4 |
GO:0016126 | sterol biosynthetic process | 1.573695e-4 |
GO:0035630 | bone mineralization involved in bone maturation | 1.580952e-4 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.635898e-4 |
GO:0043267 | negative regulation of potassium ion transport | 1.635898e-4 |
GO:0010155 | regulation of proton transport | 1.635898e-4 |
GO:0000255 | allantoin metabolic process | 1.648127e-4 |
GO:0046339 | diacylglycerol metabolic process | 1.651856e-4 |
GO:0072337 | modified amino acid transport | 1.654543e-4 |
GO:0042537 | benzene-containing compound metabolic process | 1.680092e-4 |
GO:0001508 | regulation of action potential | 1.724646e-4 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.726806e-4 |
GO:0050918 | positive chemotaxis | 1.747540e-4 |
GO:0045824 | negative regulation of innate immune response | 1.815832e-4 |
GO:0032755 | positive regulation of interleukin-6 production | 1.851458e-4 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 1.859662e-4 |
GO:0006012 | galactose metabolic process | 1.870745e-4 |
GO:0070670 | response to interleukin-4 | 1.914516e-4 |
GO:0006099 | tricarboxylic acid cycle | 1.944911e-4 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 1.952738e-4 |
GO:0046356 | acetyl-CoA catabolic process | 1.977388e-4 |
GO:0060012 | synaptic transmission, glycinergic | 2.034723e-4 |
GO:0006507 | GPI anchor release | 2.034723e-4 |
GO:0002026 | regulation of the force of heart contraction | 2.049870e-4 |
GO:0060416 | response to growth hormone stimulus | 2.054010e-4 |
GO:0010574 | regulation of vascular endothelial growth factor production | 2.064246e-4 |
GO:0007586 | digestion | 2.082983e-4 |
GO:0042110 | T cell activation | 2.084166e-4 |
GO:0045821 | positive regulation of glycolysis | 2.105232e-4 |
GO:0014065 | phosphatidylinositol 3-kinase cascade | 2.143915e-4 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 2.155683e-4 |
GO:0018872 | arsonoacetate metabolic process | 2.155683e-4 |
GO:0050856 | regulation of T cell receptor signaling pathway | 2.198377e-4 |
GO:0055002 | striated muscle cell development | 2.257048e-4 |
GO:0061037 | negative regulation of cartilage development | 2.285721e-4 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 2.287928e-4 |
GO:0043901 | negative regulation of multi-organism process | 2.298999e-4 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 2.307764e-4 |
GO:0071398 | cellular response to fatty acid | 2.340613e-4 |
GO:0019362 | pyridine nucleotide metabolic process | 2.345301e-4 |
GO:0060816 | random inactivation of X chromosome | 2.346745e-4 |
GO:0009746 | response to hexose stimulus | 2.379602e-4 |
GO:0009064 | glutamine family amino acid metabolic process | 2.385657e-4 |
GO:0031667 | response to nutrient levels | 2.401585e-4 |
GO:0031000 | response to caffeine | 2.425280e-4 |
GO:0071379 | cellular response to prostaglandin stimulus | 2.443469e-4 |
GO:0044282 | small molecule catabolic process | 2.460441e-4 |
GO:0045768 | positive regulation of anti-apoptosis | 2.464609e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 2.469355e-4 |
GO:0044106 | cellular amine metabolic process | 2.508834e-4 |
GO:0046709 | IDP catabolic process | 2.509362e-4 |
GO:0046032 | ADP catabolic process | 2.509362e-4 |
GO:0072592 | oxygen metabolic process | 2.511230e-4 |
GO:0009060 | aerobic respiration | 2.539323e-4 |
GO:0009308 | amine metabolic process | 2.612345e-4 |
GO:0002237 | response to molecule of bacterial origin | 2.626816e-4 |
GO:0060674 | placenta blood vessel development | 2.630336e-4 |
GO:0002252 | immune effector process | 2.682323e-4 |
GO:0032674 | regulation of interleukin-5 production | 2.746391e-4 |
GO:0070542 | response to fatty acid | 2.747064e-4 |
GO:0060711 | labyrinthine layer development | 2.753528e-4 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 2.793575e-4 |
GO:0009404 | toxin metabolic process | 2.793575e-4 |
GO:0002883 | regulation of hypersensitivity | 2.796277e-4 |
GO:0006720 | isoprenoid metabolic process | 2.890842e-4 |
GO:0001775 | cell activation | 2.899204e-4 |
GO:0042445 | hormone metabolic process | 2.933082e-4 |
GO:0060402 | calcium ion transport into cytosol | 2.947539e-4 |
GO:0002821 | positive regulation of adaptive immune response | 2.948088e-4 |
GO:0061077 | chaperone-mediated protein folding | 2.978728e-4 |
GO:0007606 | sensory perception of chemical stimulus | 2.985542e-4 |
GO:0019693 | ribose phosphate metabolic process | 3.032193e-4 |
GO:0032714 | negative regulation of interleukin-5 production | 3.040829e-4 |
GO:0009615 | response to virus | 3.104393e-4 |
GO:0048878 | chemical homeostasis | 3.110511e-4 |
GO:0009593 | detection of chemical stimulus | 3.127537e-4 |
GO:0006695 | cholesterol biosynthetic process | 3.135893e-4 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 3.185431e-4 |
GO:0008050 | female courtship behavior | 3.219187e-4 |
GO:0072668 | tubulin complex biogenesis | 3.285844e-4 |
GO:0070309 | lens fiber cell morphogenesis | 3.285844e-4 |
GO:0046470 | phosphatidylcholine metabolic process | 3.405480e-4 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 3.408767e-4 |
GO:0010886 | positive regulation of cholesterol storage | 3.445098e-4 |
GO:0032844 | regulation of homeostatic process | 3.475544e-4 |
GO:0002699 | positive regulation of immune effector process | 3.534798e-4 |
GO:0030888 | regulation of B cell proliferation | 3.636876e-4 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 3.640416e-4 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 3.696718e-4 |
GO:0043691 | reverse cholesterol transport | 3.708098e-4 |
GO:0006105 | succinate metabolic process | 3.719018e-4 |
GO:0045321 | leukocyte activation | 3.820827e-4 |
GO:0031100 | organ regeneration | 3.989619e-4 |
GO:0015851 | nucleobase transport | 4.022679e-4 |
GO:0046649 | lymphocyte activation | 4.082545e-4 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 4.103518e-4 |
GO:0030502 | negative regulation of bone mineralization | 4.127168e-4 |
GO:0044058 | regulation of digestive system process | 4.278273e-4 |
GO:0042592 | homeostatic process | 4.311806e-4 |
GO:0033574 | response to testosterone stimulus | 4.362413e-4 |
GO:0009134 | nucleoside diphosphate catabolic process | 4.407555e-4 |
GO:0070741 | response to interleukin-6 | 4.437299e-4 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 4.456306e-4 |
GO:0043154 | negative regulation of caspase activity | 4.518981e-4 |
GO:0014074 | response to purine-containing compound | 4.558036e-4 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 4.659854e-4 |
GO:0010994 | free ubiquitin chain polymerization | 4.713365e-4 |
GO:0010226 | response to lithium ion | 4.745067e-4 |
GO:0071320 | cellular response to cAMP | 4.761875e-4 |
GO:0002697 | regulation of immune effector process | 4.819532e-4 |
GO:0001558 | regulation of cell growth | 4.831547e-4 |
GO:0006520 | cellular amino acid metabolic process | 4.864207e-4 |
GO:0050868 | negative regulation of T cell activation | 4.900726e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 4.915202e-4 |
GO:0009063 | cellular amino acid catabolic process | 4.997644e-4 |
GO:0006954 | inflammatory response | 5.077923e-4 |
GO:0051583 | dopamine uptake | 5.168445e-4 |
GO:0015747 | urate transport | 5.168445e-4 |
GO:0097029 | mature dendritic cell differentiation | 5.213114e-4 |
GO:0018106 | peptidyl-histidine phosphorylation | 5.266038e-4 |
GO:0048856 | anatomical structure development | 5.350207e-4 |
GO:0002679 | respiratory burst involved in defense response | 5.398294e-4 |
GO:0002695 | negative regulation of leukocyte activation | 5.458610e-4 |
GO:0031274 | positive regulation of pseudopodium assembly | 5.678230e-4 |
GO:0001701 | in utero embryonic development | 5.715182e-4 |
GO:0006863 | purine base transport | 5.893437e-4 |
GO:0051712 | positive regulation of killing of cells of other organism | 5.917998e-4 |
GO:0032496 | response to lipopolysaccharide | 5.925605e-4 |
GO:0070168 | negative regulation of biomineral tissue development | 5.958375e-4 |
GO:0045416 | positive regulation of interleukin-8 biosynthetic process | 6.314759e-4 |
GO:0034754 | cellular hormone metabolic process | 6.331126e-4 |
GO:0046651 | lymphocyte proliferation | 6.519744e-4 |
GO:0002885 | positive regulation of hypersensitivity | 6.546139e-4 |
GO:0045721 | negative regulation of gluconeogenesis | 6.614750e-4 |
GO:0006734 | NADH metabolic process | 6.646430e-4 |
GO:0070301 | cellular response to hydrogen peroxide | 6.781478e-4 |
GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 6.819561e-4 |
GO:0050927 | positive regulation of positive chemotaxis | 6.883949e-4 |
GO:0006548 | histidine catabolic process | 6.925737e-4 |
GO:0031952 | regulation of protein autophosphorylation | 6.977850e-4 |
GO:0032675 | regulation of interleukin-6 production | 6.979594e-4 |
GO:0008285 | negative regulation of cell proliferation | 7.032575e-4 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 7.172829e-4 |
GO:0018924 | mandelate metabolic process | 7.172829e-4 |
GO:0032386 | regulation of intracellular transport | 7.216161e-4 |
GO:0042447 | hormone catabolic process | 7.312280e-4 |
GO:0006873 | cellular ion homeostasis | 7.410173e-4 |
GO:0048015 | phosphatidylinositol-mediated signaling | 7.491491e-4 |
GO:0002149 | hypochlorous acid biosynthetic process | 7.552509e-4 |
GO:0000003 | reproduction | 7.623933e-4 |
GO:0030279 | negative regulation of ossification | 7.716253e-4 |
GO:0042542 | response to hydrogen peroxide | 7.784892e-4 |
GO:0048747 | muscle fiber development | 7.929314e-4 |
GO:0042403 | thyroid hormone metabolic process | 7.929499e-4 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 7.948038e-4 |
GO:0045767 | regulation of anti-apoptosis | 7.995327e-4 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 8.139723e-4 |
GO:0032387 | negative regulation of intracellular transport | 8.163798e-4 |
GO:0002253 | activation of immune response | 8.253162e-4 |
GO:0070661 | leukocyte proliferation | 8.440984e-4 |
GO:0060013 | righting reflex | 8.447156e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 8.541267e-4 |
GO:0002118 | aggressive behavior | 8.596331e-4 |
GO:0008016 | regulation of heart contraction | 8.642804e-4 |
GO:0045338 | farnesyl diphosphate metabolic process | 8.741386e-4 |
GO:0006101 | citrate metabolic process | 8.959932e-4 |
GO:0009310 | amine catabolic process | 9.127339e-4 |
GO:0061061 | muscle structure development | 9.132990e-4 |
GO:0042692 | muscle cell differentiation | 9.216747e-4 |
GO:0010970 | microtubule-based transport | 9.293535e-4 |
GO:0009072 | aromatic amino acid family metabolic process | 9.322836e-4 |
GO:0043501 | skeletal muscle adaptation | 9.372908e-4 |
GO:0007021 | tubulin complex assembly | 9.376776e-4 |
GO:0055001 | muscle cell development | 9.411275e-4 |
GO:0010821 | regulation of mitochondrion organization | 9.519750e-4 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 9.583250e-4 |
GO:0034614 | cellular response to reactive oxygen species | 9.618894e-4 |
GO:0032103 | positive regulation of response to external stimulus | 9.697054e-4 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.744055e-4 |
GO:0031915 | positive regulation of synaptic plasticity | 9.754211e-4 |
GO:0009612 | response to mechanical stimulus | 1.007969e-3 |
GO:0009395 | phospholipid catabolic process | 1.009525e-3 |
GO:0051336 | regulation of hydrolase activity | 1.011407e-3 |
GO:0060900 | embryonic camera-type eye formation | 1.019166e-3 |
GO:0046395 | carboxylic acid catabolic process | 1.024887e-3 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1.053633e-3 |
GO:0048048 | embryonic eye morphogenesis | 1.053740e-3 |
GO:0008088 | axon cargo transport | 1.093357e-3 |
GO:0031116 | positive regulation of microtubule polymerization | 1.093357e-3 |
GO:0071615 | oxidative deethylation | 1.094241e-3 |
GO:0045090 | retroviral genome replication | 1.094241e-3 |
GO:0009403 | toxin biosynthetic process | 1.094241e-3 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 1.094241e-3 |
GO:0007619 | courtship behavior | 1.095835e-3 |
GO:0033700 | phospholipid efflux | 1.108844e-3 |
GO:0048676 | axon extension involved in development | 1.110465e-3 |
GO:0051384 | response to glucocorticoid stimulus | 1.116080e-3 |
GO:0048738 | cardiac muscle tissue development | 1.116085e-3 |
GO:0023057 | negative regulation of signaling | 1.116332e-3 |
GO:0031016 | pancreas development | 1.120584e-3 |
GO:0045926 | negative regulation of growth | 1.121383e-3 |
GO:0030101 | natural killer cell activation | 1.129283e-3 |
GO:0007525 | somatic muscle development | 1.148903e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.152108e-3 |
GO:0042157 | lipoprotein metabolic process | 1.154516e-3 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 1.175425e-3 |
GO:0006641 | triglyceride metabolic process | 1.185765e-3 |
GO:0031272 | regulation of pseudopodium assembly | 1.190210e-3 |
GO:0019695 | choline metabolic process | 1.194589e-3 |
GO:0061029 | eyelid development in camera-type eye | 1.215394e-3 |
GO:0006812 | cation transport | 1.216455e-3 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 1.225311e-3 |